Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a minor site revision label 'Revision: v3.4.2' and removes the prior 'Revision: v3.4.1' label, including a government funding status notice.SummaryDifference0.2%

- Check21 days agoChange DetectedNew documents and external references were added to the study page, including the Study Protocol PDF, Statistical Analysis Plan PDF, IPD sharing information, and publications from PubMed.SummaryDifference98%

- Check28 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Deleted: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No visible changes to content or functionality were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section reorganized into a centralized master list, adding study sites across the United States, Canada, and Europe. Previously separate location entries (e.g., Arizona Locations, California Locations) were removed in favor of the consolidated Locations listing.SummaryDifference2%

- Check92 days agoChange DetectedThe Publications section now states that items are automatically filled in from PubMed, replacing the previous wording, and the page revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.